Home/Publication/IDG & Mirae Lead in BioTech Play
IDG & Mirae Lead in BioTech Play 

11 Jun 2024

US$ 19.00

IDG Capital and Mirae Asset Financial Group have co-led the series B+ financing round of Chengdu Pukang ......

Price / article: US$19.00
OR existing subscriber
Related Publications

KKR & Co Inc and the Portugal-based Quadrantis Capital have agreed to purchase an aggregate 13.07% stake in Peak ......

MBK Partners (MBK) is to conclude its 6-years long investment in Shanghai Siyanli Industrial Co Ltd ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.